Her2 Status in Small Intestinal Adenocarcinoma

被引：0
|
作者：
Chan, O. T. M.
Chen, Z.
Phan, D. C.
Himmelfarb, E.
Wang, H. L.
机构：
[1] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
[2] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA
来源：
LABORATORY INVESTIGATION | 2010年 / 90卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
618
引用
收藏
页码：140A / 140A
页数：1
相关论文
共 50 条
  • [21] Status of HER1 and HER2 in peritoneal, ovarian and colorectal endometriosis and ovarian endometrioid adenocarcinoma
    C. Uzan
    E. Darai
    A. Valent
    O. Graesslin
    A. Cortez
    R. Rouzier
    P. Vielh
    Virchows Archiv, 2009, 454 : 525 - 529
  • [22] Reassessment of HER2 status in breast cancer patients with initially HER2 negative or HER2 unknown primary tumors at the time of metastatic disease by serum HER2 and HER2 status of circulating tumor cells
    Fehm, T.
    Solomayer, E.
    Uhr, J.
    Wallwiener, D.
    ONKOLOGIE, 2008, 31 : 51 - 51
  • [23] Comparison of HER2 status between surgically resected specimens and matched biopsy specimens of gastric intestinal-type adenocarcinoma
    Hiroshi Yoshida
    Noriko Yamamoto
    Hirokazu Taniguchi
    Ichiro Oda
    Hitoshi Katai
    Ryoji Kushima
    Hitoshi Tsuda
    Virchows Archiv, 2014, 465 : 145 - 154
  • [24] Comparison of HER2 status between surgically resected specimens and matched biopsy specimens of gastric intestinal-type adenocarcinoma
    Yoshida, Hiroshi
    Yamamoto, Noriko
    Taniguchi, Hirokazu
    Oda, Ichiro
    Katai, Hitoshi
    Kushima, Ryoji
    Tsuda, Hitoshi
    VIRCHOWS ARCHIV, 2014, 465 (02) : 145 - 154
  • [25] HER2 Gene Protein Assay Is Useful to Determine HER2 Status and Evaluate HER2 Heterogeneity in HER2 Equivocal Breast Cancer
    Hou, Yanjun
    Nitta, Hiroaki
    Li, Zaibo
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2017, 147 (01) : 89 - 95
  • [26] Evaluation of analytical accuracy of HER2 status in patients with breast cancer Comparison of HER2 GPA with HER2 IHC and HER2 FISH
    Jensen, Steffen Grann
    Thomas, Peter Engel
    Christensen, Ib Jarle
    Balslev, Eva
    Hansen, Alastair
    Hogdall, Estrid
    APMIS, 2020, 128 (11) : 573 - 582
  • [27] Reassessment of HER2 status in breast cancer patients at the time of metastatic disease by serum HER2 and HER2 status of circulating tumor cells
    Fehm, Tania
    TUMOR BIOLOGY, 2007, 28 : 22 - 22
  • [28] Lung adenocarcinoma: Sustained subtyping with immunohistochemistry and EGFR, HER2 and KRAS mutational status
    Sousa, Vitor
    Rodrigues, Carolina
    Silva, Maria
    Alarcao, Ana Maria
    Carvalho, Lina
    REVISTA PORTUGUESA DE PNEUMOLOGIA, 2015, 21 (03) : 113 - 125
  • [29] Impact of HER2 status in resected gastric or gastroesophageal junction adenocarcinoma in a Western population
    Martinez Lago, Nieves
    Vieito Villar, Maria
    Varela Ponte, Rafael
    Abdulkader Nallib, Ihab
    Carrera Alvarez, Juan Jose
    Antunez Lopez, Jose Ramon
    Lopez Lopez, Rafael
    Padin Iruegas, Maria Elena
    ECANCERMEDICALSCIENCE, 2020, 14
  • [30] Inconsistency of HER2 Status Between Core Needle Biopsy and Surgical Specimens: Focus on HER2 Null, HER2 Ultralow, and HER2 Low
    Wu, Si
    Liu, Hongbo
    Liu, Yueping
    LABORATORY INVESTIGATION, 2025, 105 (03)
12345